Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2

Clinical trial NCT07076056 · COMPLETED

Trial details

NCT number: NCT07076056
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-10-27
Primary completion: 2023-12-04
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.